Cheezheng

Cheezheng (奇正藏药) is the brand name associated with a Chinese pharmaceutical business focused on Tibetan medicine. The company is commonly identified as Gansu Qizheng Tibetan Medicine Co., Ltd. and is associated with the development and sale of medicines rooted in Tibetan medical traditions, including topical products for pain and musculoskeletal complaints. Its best-known offering is Qizheng Xiaotong Plaster, a topical analgesic plaster. The business was founded by Lei Jufang and is generally reported as having been established in 1993 in Gansu, China. It subsequently became a publicly listed company in Shenzhen. Its principal market is China. Detailed information about its current product catalogue, leadership, ownership structure, and international operations cannot be confirmed from the evidence supplied here. The supplied website address currently displays a domain-sale notice rather than corporate or product information. Accordingly, that page does not independently verify the company’s history, products, or current operations.

Cheezheng is associated with a Chinese pharmaceutical business specializing in Tibetan medicine. The company is commonly identified as Gansu Qizheng Tibetan Medicine Co., Ltd. and is associated with founder Lei Jufang. It is generally reported to have been established in Gansu in 1993. Its business has centered on developing and commercializing medicines drawing on Tibetan medical traditions, with topical treatments among its recognizable product types. One widely recognized offering associated with the brand is Qizheng Xiaotong Plaster, a topical analgesic plaster. The company is also commonly reported to have become publicly listed in Shenzhen. China is its principal market. Specific verified dates for product introductions, changes in corporate ownership, leadership appointments, and overseas expansion are not available from the evidence supplied for this dossier, so no additional dated milestones are asserted. The supplied website URL, https://www.qizheng.com, currently presents a domain-sale notice under the title “FUMI.com.” That notice does not provide corporate history or product information and does not, by itself, establish whether the address remains an official company website. The supplied material therefore offers no direct confirmation of Cheezheng’s current catalogue, management, or operating structure.

• 1993

  Company established

• Public listing

A Chinese pharmaceutical brand centered on Tibetan medicine and traditional therapeutic products.

• Qizheng Xiaotong Plaster

  A topical analgesic plaster associated with the Cheezheng brand.

• 2023

  Qizheng Tibetan Medicine, Chairwoman Lei Jufang Warned Over Undisclosed RMB151M Related-Party CD Deals With Controlling Shareholder

  From August 2022 to March 2023, Qizheng Tibetan Medicine and controlling shareholder Gansu Qizheng Industrial cumulatively traded transferable large-denomination certificates of deposit worth RMB151 million, without going through review procedures and without disclosing them in periodic reports. The Tibet Securities Regulatory Bureau issued warning letters to the company and Chairwoman Lei Jufang, General Manager Liu Kailie, CFO Yao Xiaomei, and Board Secretary Feng Ping; in December, the Shenzhen Stock Exchange issued a regulatory letter based on cumulative related-party transactions of RMB181 million. Status: regulatory measures. Entities involved: Tibet Qizheng Tibetan Medicine Co., Ltd., Gansu Qizheng Industrial Group Co., Ltd., Lei Jufang. Scope: related-party transactions.

  Source

Read more

1. 1FUMI.com (domain-sale notice displayed at supplied address)qizheng.com
2. 2Qizheng Tibetan Medicine, Chairwoman Lei Jufang Warned Over Undisclosed RMB151M Related-Party CD Deals With Controlling Shareholdercsrc.gov.cn
3. 3Qizheng Tibetan Medicine, Chairwoman Lei Jufang Warned Over Undisclosed RMB151M Related-Party CD Deals With Controlling Shareholdercsrc.gov.cn
4. 4Qizheng Tibetan Medicine, Chairwoman Lei Jufang Warned Over Undisclosed RMB151M Related-Party CD Deals With Controlling Shareholderm.bjnews.com.cn